Podocyte expression of Hypoxia-Inducible Factor (HIF)-1 and HIF-2 during glomerular development

Journal of the American Society of Nephrology

Volumn 14, Issue 4, 2003, Pages 927-938

  Freeburg, Paul B ^a   Robert, Barry ^a   St John, Patricia L ^a   Abrahamson, Dale R ^a  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1; HYPOXIA INDUCIBLE FACTOR 2; PIMONIDAZOLE; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL SURVIVAL; EMBRYO DEVELOPMENT; ENDOTHELIUM CELL; GENE TARGETING; GLOMERULUS BASEMENT MEMBRANE; GLYCOLYSIS; HYDROXYLATION; IMMUNOHISTOCHEMISTRY; KIDNEY CORTEX; KIDNEY DEVELOPMENT; METABOLIC ACTIVATION; MOUSE; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PODOCYTE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSACTIVATION;

EID: 0037378943     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ASN.0000059308.82322.4F     Document Type: Article

References (58)

1. 2 tension. Proc Natl Acad Sci USA 92: 5510-5514, 1995
2. Jiang BH, Rue E, Wang GL, Semenza GL: Dimerization, DNA binding, and transactivation properties of hypoxia-inducible factor 1. J Biol Chem 271: 17771-17778, 1996
3. Wang GL, Semenza GL: Purification and characterization of HIF-1. J Biol Chem 270: 1230-1237, 1995
4. Flamme I, Frohlich T, von Reutern M, Kappel A, Damert A, Risau W: HRF, a putative basic helix-loop-helix-PAS-domain transcription factor is closely related to hypoxia-inducible factor 1α and developmentally expressed in blood vessels. Mech Dev 63: 51-60, 1997
5. 2-regulated prolyl hydroxylation. Science 292: 468-472, 2001
6. Kallio PJ, Wilson WJ, O'Brien S, Makino Y, Tanaka H, Poellinger L: Regulation of the hypoxia-inducible transcription factor 1α by the ubiquitin-proteasome pathway. J Biol Chem 274: 6519-6525, 1999
7. Lando D, Peet DJ, Whelan DA, Gorman JJ, Whitelaw ML: Asparagine hydroxylation of the HIF transactivation domain a hypoxic switch. Science 295: 807-808, 2002
8. Semenza GL: HIF-1 and human disease: One highly involved factor. Genes Dev 14: 1983-1991, 2000
9. Semenza GL: Hypoxia, clonal selection, and the role of HIF-1 in tumor progression. Crit Rev Biochem Mol Biol 35: 71-103, 2000
10. 2 homeostasis by hypoxia-inducible factor 1α. Genes Dev 12: 149-162, 1998
11. Ryan HE, Lo J, Johnson RS: HIF-1α is required for solid tumor formation and embryonic vascularization. EMBO J 17: 3003-3015, 1998
12. Peng J, Zhang L, Drysdale L, Fong GH: The transcription factor EPAS-1/hypoxia-inducible factor 2alpha plays an important role in vascular remodeling. Proc Natl Acad Sci USA 97: 8386-8391, 2000
13. Tian H, Hammer RE, Matsumoto AM, Russell DW, McKnight SL: The hypoxia-responsive transcription factor EPAS1 is essential for catecholamine homeostasis and protection against heart failure during embryonic development. Genes Dev 12: 3320-3324, 1998
14. Maltepe E, Schmidt JV, Baunoch D, Bradford CA, Simon MC: Abnormal angiogenesis and responses to glucose deprivation in mice lacking the protein ARNT. Nature 386: 403-407, 1997
15. Lee YM, Jeong CH, Koo SY, Son MJ, Song HS, Bae SK, Raleigh JA, Chung HY, Yoo MA, Kim KW: Determination of hypoxic region by hypoxia marker in developing mouse embryos in vivo: A possible signal for vessel development. Dev Dyn 220: 175-186, 2001
16. Levy AP, Levy NS, Wegner S, Goldberg MA: Transcriptional regulation of the rat vascular endothelial growth factor gene by hypoxia. J Biol Chem 270: 13333-13340, 1995
17. Liu Y, Cox SR, Morita T, Kourenbanas S: Hypoxia regulates VEGF expression in endothelial cells: Identification of a 5′ enhancer. Circ Res 77: 638-643, 1995
18. Carmeliet P, Ferreira V, Breier G, Pollefeyt S, Kieckens L, Gertsenstein M, Fahrig M, Vandenhoeck M, Harpel K, Eberhardt C, Declercq C, Pawling J, Moons L, Collen D, Risau W, Nagy A: Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 380: 435-439, 1996
19. Ferrara N, Carver-Moore K, Chen H, Dowd M, Lu L, O'Shea KS, Powell-Braxton L, Hillan KJ, Moore MW: Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature 380: 439-442, 1996
20. Shalaby F, Rossant J, Yamaguchi TP, Gertsenstein M, Wu XF, Breitman ML, Schuch AC: Failure of blood island formation and vasculogenesis in Flk-1-deficient mice. Nature 376: 62-66, 1995
21. Fong G-H, Rossant J, Gertenstein M, Breitman ML: Role of the Flt-1 receptor kinase in regulating the assembly of vascular endothelium. Nature 376: 66-70, 1995
22. Sato TN, Tozawa Y, Deutsch U, Wolburg-Buchholz K, Fujiwara Y, Gendron L, Maguire M, Gridley T, Wolburg H, Risau W, Qin Y: Distinct roles for the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation. Nature 376: 70-74, 1995
23. Davis S, Aldrich TH, Jones PF, Acheson A, Compton DL, Jain V, Ryan TE, Bruno J, Radziejewski C, Mainonpierre PC, Yancopoulos GD: Isolation of angiopoietin-1, a ligand for the Tie-2 receptor, by secretion-trap expression cloning. Cell 87: 1161-1170, 1996
24. Mainonpierre PC, Suri C, Jones PF, Bartunkova S, Wiegand SJ, Radziejewski C, Compton D, McClain J, Aldrich TH, Papadopoulos N, Daly TJ, Davis S, Sato TN, Yancopoulos GD: Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science 277: 55-60, 1997
25. Stratmann A, Risau W, Plate KH: Cell type-specific expression of angiopoietin-1 and angiopoietin-2 suggests a role in glioblastoma angiogenesis. Am J Pathol 153: 1459-1466, 1998
26. Dumont DJ, Fong GH, Puri MC, Gradwohl G, Alitalo K, Breitman ML: Vascularization of the mouse embryo: A study of Flkl, Tek, Tie, and vascular endothelilal growth factor expression during development. Dev Dyn 203: 80-92, 1995
27. Kitamoto Y, Tokunaga H, Tomita K: Vascular endothelial growth factor is an essential molecule for mouse kidney development: Glomerulogenesis and nephrogenesis. J Clin Invest 99: 2351-2357, 1997
28. Simon M, Grone H-J, Johren O, Kullmer J, Plate HK, Risau W, Fuchs E: Expression of vascular endothelial growth factor and its receptors in human renal ontogenesis and in adult kidney. Am J Physiol 268: F240-F250, 1995
29. Robert B, St. John PL, Hyink DP, Abrahamson DR: Evidence that embryonic kidney cells expressing flk-1 are intrinsic, vasculogenic angioblasts. Am J Physiol 271: F744-F753, 1996
30. Robert B, St. John PL, Abrahamson DR: Direct visualization of renal vascular morphogenesis in Flkl heterozygous mutant mice. Am J Physiol 275: F164-F172, 1998
31. Gerber HP, Hillan KJ, Ryan AM, Kowalski J, Keller GA, Rangell L, Wright BD, Radtke F, Aguet M, Ferrara N: VEGF is required for growth and survival in neonatal mice. Development 126: 1149-1159, 1999
32. Gerber HP, Condorelli F, Park J, Ferrara N: Differential transcriptional regulation of the two vascular endothelial growth factor receptor genes: Flt-1, but not Flk-1/KDR, is upregulated in hypoxia. J Biol Chem 272: 23659-23667, 1997
33. Kappel A, Ronicke V, Damert A, Flamme I, Risau W, Breir, G: Identification of vascular endothelial growth factor (VEGF) receptor-2 (Flk-1) promoter/enhancer sequences sufficient for angioblast and endothelial cell-specific transcription in transgenic mice. Blood 93: 4284-4292, 1999
34. Tufro-McReddie A, Norwood VF, Aylor KW, Botkin SJ, Carey RM, Gomez RA: Oxygen regulates vascular endothelial growth factor-mediated vasculogenesis and tubulogenesis. Dev Biol 183: 139-149, 1997
35. Loughna S, Yuan HT, Woolf AS: Effects of oxygen on vascularization patterning in Tiel/LacZ metanephric kidneys in vitro. Biochem Biophys Res Comm 247: 361-366, 1998
36. Yuan HT, Suri C, Yancopoulos GD, Woolf AS: Expression of Angiopoietin-1. Angiopoietin-2 and the Tie-2 receptor tyrosine kinase during mouse kidney maturation. J Am Soc Nephrol 10: 1722-1736, 1999
37. Yuan HT, Suri C, Landon DN, Yancopoulos GD, Woolf AS: Angiopoietin-2 is a site-specific factor in differentiation of mouse renal vasculature. J Am Soc Nephrol 11: 1055-1066, 2000
38. Yuan HT, Yang SP, Woolf AS: Hypoxia up-regulates angiopoietin-2, a Tie-2 ligand, in mouse mesangial cells. Kidney Int 58: 1912-1919, 2000
39. Abrahamson DR: Glomerulogenesis in the developing kidney. Semin Nephrol 11: 375-389, 1991
40. Tian H, McKnight SL, Russell DW: Endothelial PAS domain protein 1 (EPAS 1), a transcription factor selectively expressed in endothelial cells. Genes Dev 11: 72-82, 1997
41. Stroka DM, Burkhardt T, Desbaillets I, Wenger RH, Neil DA, Bauer C, Gassmann M, Candinas D: HIF-1 is expressed in normoxic tissue and displays an organ-specific regulation under systemic hypoxia. FASEB J 15: 2445-2453, 2001
42. Wenger RH, Rolfs A, Spielmann P, Zimmerman DR, Gassmann M: Mouse hypoxia-inducible factor-1alpha is encoded by two different mRNA isoforms: expression from a tissue-specific and a housekeeping-type promoter. Blood 91: 3471-3480, 1998
43. Kietzmann T, Cornesse Y, Brechtel K, Modaressi S, Jungermann K: Perivenous expression of the mRNA of the three hypoxiainducible factor alpha-subunits, HIF1alpha, HIF2alpha and HIF3alpha, in rat liver. Biochem J 15: 531-537, 2001
44. Wiesener MS, Turley H, Allen WE, William C, Eckardt KU, Talks KL, Wood SM, Gatter KC, Harris AL, Pugh CW, Ratcliffe PJ: Induction of endothelial PAS domain protein-1 by hypoxia: characterization and comparison with hypoxia-inducible factor-1α. Blood 92: 2260-2268, 1998
45. Catron T, Mendiola MA, Smith SM, Born J, Walker MK: Hypoxia regulates avian cardiac Arnt and HIF-1 alpha mRNA expression. Biochem Biophys Res Commun 282: 602-607, 2001
46. Wiener CM, Booth G, Semenza GL: In vivo expression of mRNAs encoding hypoxia-inducible factor 1. Biochem Biophys Res Commun 225: 485-488, 1996
47. Yu AY, Frid MG, Shimoda LA, Weiner CM, Stenmark K, Semenza GL: Temporal, spatial, and oxygen-regulated expression of hypoxia-inducible factor 1 in the lung. Am J Physiol 275: L818-L826, 1998
48. Brezis M, Heyman SN, Dinour D, Epstein FH, Rosen S: Role of nitric oxide in renal medullary oxygenation. J Clin Invest 88: 390-395, 1991
49. Liss P, Nygren A, Erikson U, Ulfendahl HR: Injection of low and iso-osmolar contrast medium decreases oxygen tension in the renal medulla. Kidney Int 53: 698-702, 1998
50. Rosen S, Epstein FH, Brezis M: Determinants of intrarenal oxygenation: Factors in acute renal failure. Ren Fail 14: 321-325, 1992
51. Rosenberger C, Mandriota S, Jurgensen JS, Weisner MS, Horstrup JH, Frei U, Ratcliffe PJ, Maxwell PH, Bachmann S, Eckardt K: Expression of Hypoxia-Inducible Factor-1α and -2α in Hypoxic and Ischemic Rat Kidneys. J Am Soc Nephrol 13: 1721-1732, 2002
52. Arteel GE, Thurman RG, Yates JM, Raleigh JA: Evidence that hypoxia markers detect oxygen gradients in liver: pimonidazloe and retrograde perfusion of rat liver. Brit J Cancer 72: 889-895, 1995
53. Jiang BH, Semenza GL, Bauer C, Marti HH: HIF-1 levels vary exponentially over a physiologically relevant range of oxygen tension. Am J Physiol 271: C1172-C1180, 1996
54. Treins C, Giorgetti-Peraldi S, Murdaca J, Semenza GL, Van Obberghen E: Insulin stimulates hypoxia-inducible factor 1 through a phosphatidylinositol 3-kinase/target of rapamycin-dependent signaling pathway. J Biol Chem 277: 27975-27981, 2002
55. Chavez JC, LaManna JC: Activation of hypoxia-inducible factor-1 in the rat cerebral cortex after transient global ischemia: Potential role of insulin-like growth factor-1. J Neurosci 22: 8922-8931, 2002
56. Sandau KB, Fandrey J, Brune B: Accumulation of HIF-1α under the influence of nitric oxide. Blood 97: 1009-1015, 2001
57. Hellwig-Burgel T, Rutkowski K, Metzen E, Fandrey J, Jelkmann W: Interleukin-1β and tumor necrosis factor-a stimulate DNA binding of hypoxia-inducible factor-1. Blood 94: 1561-1567, 1999
58. Richard DE, Berra E, Pouyssegur J: Nonhypoxic pathway mediates the induction of hypoxia-inducible factor 1α in vascular smooth muscle cells. J Biol Chem 275: 26765-26771, 2000